Leading brokers have named Evolution Mining Ltd (ASX:EVN) and these ASX shares as sells this week. Here’s why they are bearish…
The post Leading brokers name 3 ASX shares to sell today appeared first on Motley Fool Australia. –
On Monday I looked at three ASX shares that brokers have given buy ratings to this week.
Unfortunately, not all shares are in favour with them right now. Three that have just been given sell ratings are listed below.
Here’s why these brokers are bearish on these ASX shares:
Evolution Mining Ltd (ASX: EVN)
According to a note out of Ord Minnett, its analysts have retained their sell rating but lifted their price target this gold miner’s shares to $4.50. The broker is concerned about the gold sector due to the upcoming U.S. election. It suspects that a Biden win could boost the gold price in the short term but actually weigh on it in the longer term as the near term economic growth outlook improves. The Evolution share price is trading is at $5.88.
ResMed Inc. (ASX: RMD)
A note out of the Macquarie equities desk reveals that its analysts have retained their underperform rating and $20.00 price target on this medical device company’s shares. Although the broker believes the current reimbursement environment is more favourable than in recent years, it sees competition risks. It fears this could put pressure on ResMed’s gross margin and ultimately its bottom line. The ResMed share price is changing hands for $25.50 this afternoon.
Zip Co Ltd (ASX: Z1P)
Analysts at Citi have retained their sell rating and cut the price target on this buy now pay later provider’s shares to $6.55. According to the note, the broker believes that Zip is well-placed for strong growth thanks to the increasing adoption of the payment method and its increased investment in the UK and United States. However, it sees risks to its margins from increased competition, which it fears could see it fall short of consensus growth forecasts over the medium term. Zip shares are fetching $7.14 on Tuesday.
Man who said buy Kogan shares at $3.63 says buy these 3 ASX stocks now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.
*Returns as of 6/8/2020
- Douugh and Afterpay were among the most traded shares on the ASX last week
- ASX 200 down 0.2%: Afterpay rockets on Westpac deal, Zip climbs, BHP’s Q1 update
- 3 ASX 200 shares hit with broker downgrades
- Why Afterpay, Cochlear, Dicker Data, & Zip shares are charging higher today
- Zip (ASX:Z1P) share price defies broader market-sell off. Here’s why
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of ZIPCOLTD FPO. The Motley Fool Australia has recommended ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.